ARCH Venture Fund XIII, L.P.

10% Owner; Director, 10% Owner · 3 filings · Latest: Jun 22, 2026

Kardigan, Inc.

Lyell Immunopharma, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
KARD	ARCH Venture Fund XIII, L.P.	Director, 10% Owner	Jun 22, 2026	Purchase	$16.00	1,250,000	$20.0M	15,042,035	Jun 24 8:18 PM
LYEL	ARCH Venture Fund XIII, L.P.	10% Owner	Mar 6, 2026	Purchase	$25.61	488,090	$12.5M	1,426,528	Mar 9 8:34 PM